...
首页> 外文期刊>Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research >Measures of renal function, BMD, bone loss, and osteoporotic fracture in older adults: the Rancho Bernardo study.
【24h】

Measures of renal function, BMD, bone loss, and osteoporotic fracture in older adults: the Rancho Bernardo study.

机译:老年人肾功能,骨密度,骨丢失和骨质疏松性骨折的测量:Rancho Bernardo研究。

获取原文
获取原文并翻译 | 示例

摘要

The association between bone and renal function in healthy seniors is not well studied. In this cross-sectional and longitudinal study in 1713 older men and women, creatinine clearance was significantly associated with hip BMD. If confirmed, this may warrant adding mild to moderate renal dysfunction as an indication for osteoporosis screening. INTRODUCTION: This study determined the cross-sectional and longitudinal association between measures of renal function and BMD, bone loss, and osteoporotic fracture in older adults. It determined which measure of renal function--creatinine clearance by the Cockcroft-Gault (CG) equation, estimated glomerular filtration rate by the Modification of Diet in Renal Disease (MDRD) equation, or serum creatinine--is most strongly associated with BMD and osteoporotic fracture. MATERIALS AND METHODS: This was a cross-sectional and prospective study in older community-dwelling men and women. Between 1992 and 1995, 1713 participants (average age, 71.3 +/- 11.1 years) completed standardized questionnaires, physical examinations, laboratory testing, and bone densitometry; 1023 participants returned for a follow-up visit in 1997-1999, an average of 4.1 +/- 0.9 years later. RESULTS: Calculated renal function declined with age (p < 0.001). Renal function was categorized by Kidney Disease Outcomes Quality Initiative (K/DOQI) chronic kidney disease (CKD) stage. By the CG equation, at baseline, 5.5% of participants had stage 1 CKD (glomerular filtration rate > or = 90 ml/min/1.73 m(2)), 43.0% had stage 2 CKD (60-89 ml/min/1.73 m(2)), 48.8% had stage 3 CKD (30-59 ml/min/1.73 m(2)), and 2.7% had stages 4 and 5 CKD (<30 ml/min/1.73 m(2)). Using the MDRD equation, these percents were 7.0%, 61.7%, 30.9%, and 0.5%, respectively. In cross-sectional analyses, there was a significant linear association between creatinine clearance by CG or glomerular filtration rate by MDRD and hip BMD. In prospective analyses, there was an average annual bone loss of 0.6% and a significant association between baseline CG and 4-year hip bone loss. There was no association between baseline MDRD or serum creatinine and bone loss. At baseline, 180 of 1713 participants (11%) reported at least one clinical fracture of the hip, femur, forearm, or wrist; 79 (8%) reported new clinical fractures during follow-up. Baseline renal function by any measure was not significantly associated with prevalent or incident clinical fractures. CONCLUSIONS: Although renal function measured by both CG and MDRD was associated with BMD in cross-sectional analyses, only creatinine clearance by CG predicted 4-year bone loss. If confirmed, this should be the preferred method for assessing the association between renal function and BMD. Cross-sectional associations between renal function and BMD were strongest at higher CKD stage. None of the baseline renal function estimates was associated with prevalent or incident fractures, perhaps reflecting the multifactorial etiology of fractures beyond BMD. If further studies in the elderly confirm renal function as an important predictor of bone loss and fracture, this may warrant adding mild to moderate renal dysfunction as an indication for osteoporosis screening.
机译:健康老年人中骨与肾功能之间的关联尚未得到很好的研究。在这项针对1713个老年男性和女性的横断面和纵向研究中,肌酐清除率与髋部BMD显着相关。如果得到确认,则可能需要增加轻度至中度的肾功能不全,以作为骨质疏松症筛查的指征。简介:这项研究确定了老年人肾功能和骨密度,骨质流失和骨质疏松性骨折的测量结果之间的横向和纵向相关性。它确定了哪种肾脏功能指标-通过Cockcroft-Gault(CG)方程进行肌酐清除率,通过肾脏疾病饮食的改良(MDRD)方程估算的肾小球滤过率或血清肌酐-与BMD和骨质疏松性骨折。材料和方法:这是一项针对年龄较大的居住在社区的男女的横断面和前瞻性研究。在1992年至1995年之间,有1713名参与者(平均年龄为71.3 +/- 11.1岁)完成了标准化问卷,身体检查,实验室测试和骨密度测定。 1997年至1999年,平均有4.1 +/- 0.9年的时间,有1023名参与者返回进行随访。结果:计算的肾功能随年龄下降(p <0.001)。肾脏功能按肾脏疾病结果质量倡议(K / DOQI)慢性肾脏病(CKD)阶段进行分类。根据CG方程,在基线时,有5.5%的参与者患有1期CKD(肾小球滤过率>或= 90 ml / min / 1.73 m(2)),43.0%的参与者患有2期CKD(60-89 ml / min / 1.73 m(2)),48.8%的3级CKD(30-59 ml / min / 1.73 m(2))和2.7%的4级和5级CKD(<30 ml / min / 1.73 m(2))。使用MDRD方程,这些百分比分别为7.0%,61.7%,30.9%和0.5%。在横断面分析中,CG的肌酐清除率或MDRD的肾小球滤过率与髋部BMD之间存在显着的线性关联。在前瞻性分析中,年平均骨丢失为0.6%,基线CG与4年髋骨丢失之间存在显着关联。基线MDRD或血清肌酐与骨丢失之间没有关联。基线时,在1713名参与者中,有180名(11%)报告了至少一处髋,股骨,前臂或腕部骨折。 79例(8%)在随访期间报告了新的临床骨折。不管怎样,基线肾功能与普遍或突发的临床骨折均无显着相关性。结论:尽管在横断面分析中,CG和MDRD均检测到肾功能与BMD相关,但只有CG清除肌酐才能预测4年骨丢失。如果得到确认,这应该是评估肾功能与BMD之间关联的首选方法。在较高的CKD阶段,肾功能和BMD之间的横断面联系最强。没有一项基线肾功能评估与普遍或意外骨折相关,这可能反映了BMD以外骨折的多因素病因。如果对老年人的进一步研究证实肾功能是骨丢失和骨折的重要预测指标,则可能需要增加轻度至中度肾功能不全作为骨质疏松症筛查的指征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号